Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryophyllum Pinnatum for Primary Dysmenorrhea
NCT06908044Phase 4Active, not recruiting
- Sponsor
- University of Zurich
- Start
- Jan 2025
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Bryophyllum pinnatum in primary dysmenorrhea (PD), sponsored by University of Zurich. Started Jan 2025; status: active, not recruiting.
02
Drugs
Bryophyllum pinnatum
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT06908044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06908044.